Labcorp Holdings Inc. (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today that its Board of Directors has declared a cash dividend of $0.72 per share of ...

Global Genes and Boston Children's Hospital Partner for 2025 RARE Drug Development Symposium - Equipping Rare Disease Advocates in Research and Drug Development ...

Ultragenyx Pharmaceutical received breakthrough therapy designation from the U.S. Food and Drug Administration for its drug GTX-102, which is designed to treat people with Angelman syndrome.

Pharmacogenomics and pharmacomicrobiomics—studying drug-microbiota interactions—are emerging fields critical to enhancing drug efficacy and minimizing adverse effects. The gut microbiome’s role in ...

The Neuropsychiatric Drug Development Summit returns for its eighth year as the industry’s flagship forum capturing advancements across discovery, preclinical, translational, clinical, and ...

A new cancer drug candidate has demonstrated the ability to block tumor growth without triggering a common and debilitating side effect.

Syrian authorities have arrested a cousin of former President Bashar Assad, who is under U.S. sanctions for his alleged role in drug trafficking and support to forces loyal to the ousted government.

Knee braces, water therapy and exercise are the most promising non-drug therapies for treating knee osteoarthritis, according to a new meta-analysis publishing June 18, 2025 in the open-access ...

We are delighted that The ALBORADA Drug Discovery Institute and Enhanced Genomics have joined forces to accelerate the dementia drug discovery process.

Let’s dig into the relative performance of Medpace (NASDAQ:MEDP) and its peers as we unravel the now-completed Q1 drug development inputs & services earnings season. Companies specializing in ...

Now, Deadline reports that The Social Network Part 2 is officially in development at Sony Pictures. Despite the name, this is not a straight sequel.

Admitted to legal drug use: – Didn't think it was of relevance - HONEST: Mads Mikkelsen claims he answered the questions from the US Immigrations officers truthfully.